Oral Cyclosporine in Vernal Keratoconjunctivitis: Indications, Outcomes, and Effect on Corticosteroid Use
Oral cyclosporine reduces corticosteroid use in VKC and can be considered in recalcitrant disease or in eyes with steroid-induced glaucoma and active allergy. Oral cyclosporine significantly reduced the risk of acute exacerbations, proving to be an effective modality for controlling inflammation in VKC.
Authors
- Sayan Basu (ORCID: https://orcid.org/0000-0001-5030-5003)
- Anahita Kate (ORCID: https://orcid.org/0000-0003-1999-5661)
- Neha Jain (ORCID: https://orcid.org/0000-0003-4239-5541)
- Haritha Goud Tallapelly
- Kumari Yukti
Institutions
- L V Prasad Eye Institute (IN)
Publication Details
- Journal
- Cornea
- Published
- 2025-01-09
- DOI
- https://doi.org/10.1097/ico.0000000000003786
- Citations
- 3
- Primary Topic
- Ocular Surface and Contact Lens
- Type
- article
- Field-Weighted Citation Impact
- 5.64
Funders
- Hyderabad Eye Research Foundation